Chemotherapy in stage-IV NSCLC

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Reck, Martin ^a   Gatzemeier, Ulrich ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

Chemotherapy; First line treatment; Quality of life; Second line treatment; Stage IV NSCLC

Indexed keywords

CARBOPLATIN; CISPLATIN; CISPLATIN DERIVATIVE; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IRINOTECAN; NAVELBINE; PACLITAXEL; PEMETREXED; TOPOTECAN; VINDESINE;

ADVANCED CANCER; ALOPECIA; ARTHRALGIA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONFERENCE PAPER; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEBRILE NEUTROPENIA; HOSPITAL ADMISSION; HUMAN; HYPERSENSITIVITY REACTION; LUNG NON SMALL CELL CANCER; METASTASIS; MONOTHERAPY; MYALGIA; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TIME; TOXICITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 8444234398     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.972     Document Type: Conference Paper

References (39)

1. Ginsberg R.J., Goldberg M., and Waters P.E. Surgery in non-small cell lung cancer Roth J.A. Ruckdeschel J.C. Weisenburger T.H. Thoracic Oncology 2nd edition 1995 W. B. Saunders Company Philadelphia, PA 124 146
2. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials Br Med J 311 1995 899 909
3. #1161 Stephens R.J., Fairlamb D., and Gower N. The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting Proc Am Soc Clin Oncol 21 2002 291a
4. Schiller J.H., Harrington D., and Belani C.P. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer N Engl J Med 346 2002 92 98
5. Kelly K., Crowley J., and Bunn P.A. Jr. Randomized phase III trial of Paclitaxel plus Carboplatin versus Vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 2001 3210 3218
6. Scagliotti G.V., De Marinis F., and Rinaldi M. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer J Clin Oncol 20 2002 4285 4291
7. Fossella F., Pereira J.R., and von Pawel J. Randomized, multinational, phase III study of Docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: the TAX 326 study group J Clin Oncol 21 2003 3016 3024
8. Alberola V., Camps C., and Provencio M. Cisplatin plus gemcitabine versus a cisplatin-triplet versus nonplatinum sequential doublets in advanced non-small cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial J Clin Oncol 21 2003 3207 3213
9. #1164 Rudd R.M., Gower N.H., and James L.E. Phase III randomised trial of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 21 2002 292a
10. Crino L., Scagliotti G.V., and Ricci F. Gemcitabine and Cisplatin versus Mitomycin, Ifosfamide and Cisplatin in advanced non-small cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project J Clin Oncol 17 1999 3522 3530
11. Danson S., Middleton M.R., and O'Byrne K.J. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced non-small cell lung cancer Cancer 98 2003 542 553
12. Grigorescu A.C., Draghici I.N., and Nitipir C. Gemcitabine (GEM) and carboplatin (CBDCA) versus Cisplatin (CDDP) and vinblastine (VLB) in advanced non-small cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial Lung Cancer 37 2002 9 14
13. Cardenal F., López-Cabrerizo M.P., and Antón A. Randomized phase III study of Gemcitabine-Cisplatin versus Etoposide-Cisplatin in the treatment of locally advanced of metastatic non-small cell lung cancer J Clin Oncol 17 1999 12 18
14. Giaccone G., Splinter T.A., and Debruyne C. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group J Clin Oncol 16 1998 2133 2141
15. Bonomi P., Kim K., and Fairclough D. Comparison of survival and quality of life in advanced non-small lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial J Clin Oncol 18 2000 623 631
16. Le Chevalier T., Brisgand D., and Soria J.C. Long term analysis of survival in the European randomized trial comparing Vinorelbine/Cisplatin to Vindesine/Cisplatin and Vinorelbine alone in advanced non-small cell lung cancer The Oncologist 6 suppl 1 2001 8 11
17. Le Chevalier T., Brisgand D., and Douillard J.Y. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients J Clin Oncol 14 1996 687 688
18. Negoro S., Masuda N., and Takada Y. Radomized phase III trial of irinotecan combined with cisplatin for advanced non-small cell lung cancer Br J Cancer 88 2003 335 341
19. Rosell R., Gatzemeier U., and Betticher D.C. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small cell lung cancer: a cooperative multinational trial Ann Oncol 13 2002 1539 1549
20. Mazzanti P., Massacesi C., and Rocchi M.B. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer Lung Cancer 41 2003 81 89
21. Zatloukal P., Petruzelka L., and Zemanova M. Gemcitabine plus cisplatin vs. Gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial Lung Cancer 41 2003 321 331
22. Klastersky J., Sculier J.P., and Lacroix H. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861 J Clin Oncol 8 1990 1446 1462
23. Lilenbaum R.C., Langenberg P., and Dickersin K. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma Cancer 82 1998 116 126
24. Marino P., Preatoni A., and Cantoni A. Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and metaanalysis study Lung Cancer 13 1995 1 12
25. #2 Lilenbaum R.C., Herndon J., and List M. Single-agent (SA) versus combination chemotherapy (CC) in advanced non-small cell lung cancer (NSCLC): a CALGB randomized trial of efficacy, quality of life (Qol), and cost-effectiveness Proc Am Soc Clin Oncol 21 2002 1a
26. #1162 Sederholm C. Gemcitabine (G) compared with gemcitabine plus carboplatin (GC) in advanced non-small cell lung cancer (NSCLC): a phase III study by the Swedish Lung Cancer Study Group (SLUSG) Proc Am Soc Clin Oncol 21 2002 291a
27. #1163 Georgoulias V., Ardavanis A., and Agelidou M. Preliminary analysis of a multicenter phase III trial comparing Docetaxel (D) versus Docetaxel/cisplatin (DC) in patients with inoperable advanced and metastatic non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 21 2002 291a
28. Gridelli C., Perrone F., and Gallo C. Chemotherapy for elderly patients with advanced non-small cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial J Natl Cancer Inst 95 2003 362 372
29. Ranson M., Davidson N., and Nicolson M. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small cell lung cancer J Natl Cancer Inst 92 2000 1074 1080
30. Roszkowski K., Pluzanska A., and Krzakowski M. A multicenter, randomized, phase III study of Docetaxel plus best supportive care versus best supportive care in chemotherapy-naïve patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC) Lung Cancer 27 2000 145 157
31. ELCVSG Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group J Natl Cancer Inst 91 1999 66 72
32. Anderson H., Hopwood P., and Stephens R.J. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable nonsmaLL cell lung cancer -- a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer Br J Cancer 83 2000 447 453
33. Vokes E., Rosenber E.K., and Jahanzev M. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small cell lung cancer J Clin Oncol 13 1995 637 644
34. Jassem J., Ramlau R., and Karnicka-Modkowska H. Multicenter randomised phase II study of oral versus intravenous vinorelbine in advanced non-small cell lung cancer Ann. Oncol 2001 1375 1381
35. Shepherd F.A., Dancey J., and Ramlau R. Prospective randomized trial of DocetaxeL versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy J Clin Oncol 18 2000 2095 2103
36. Petrioli R., Pozzessere D., and Messinese S. Weekly Low-dose Docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens Lung Cancer 39 2003 85 89
37. Lilenbaum R.C., Schwartzt M.A., and Seigel L. Phase II trial of weekly Docetaxel in second-line therapy for non-small cell lung carcinoma Cancer 92 2001 158 163
38. Juan O., Albert A., and Ordono F. Low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer: a phase II study Jpn J Clin Oncol 32 2002 449 454
39. PL-5 Shepherd F.A., Pereira J.R., and von Pawel J. A phase III study of permetrexed vs. docetaxel in patients with advanced non-small cell lung cancer (NSCLC) who were previously treated with chemotherapy Lung Cancer 41 Suppl 2 2003 4